NCT00058461 2013-10-08Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 2 Terminated82 enrolled